GlassScriptPhysician profile
Yili Huang
NPI 1093967184
$699,031.27
in general payments reported to CMS, 2019-2025
62 companies · $29K in 2025
The $29K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $121K · 2020: $82K · 2021: $201K · 2022: $179K · 2023: $53K · 2024: $35K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $71K · Food and Beverage: $22K · Long Term Medical Supply Or Device Loan: $20K · Travel and Lodging: $3,236 · Education: $5.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $70,655.00 |
| Food and Beverage | $22,313.74 |
| Long Term Medical Supply Or Device Loan | $20,416.67 |
| Travel and Lodging | $3,236.25 |
| Education | $5.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $353,062.28 | 2019-2024 | Xarelto |
| Esperion Therapeutics, INC. | $142,334.39 | 2020-2025 | Nexletol, Nexlizet |
| Amarin Pharma, INC. | $40,323.04 | 2019-2023 | |
| Angiodynamics, INC. | $38,740.79 | 2021-2023 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Astrazeneca Pharmaceuticals LP | $33,374.34 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $22,990.17 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $10,838.09 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $9,494.78 | 2022 | |
| Boston Scientific Corporation | $7,255.53 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, Interlock |
| Janssen Global Services, LLC | $7,198.21 | 2022 | |
| Cardiovascular Systems INC. | $4,599.92 | 2019-2023 | Diamondback Peripheral |
| Medtronic, INC. | $3,285.40 | 2022-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Abbott Laboratories | $3,216.92 | 2019-2024 | Diamondback Peripheral, Aveir, Diamondback Coronary |
| Medtronic Vascular, INC. | $2,676.90 | 2019-2020 | |
| Vifor Pharma, INC. | $2,227.71 | 2021 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,708.05 | 2023-2025 | |
| Philips North America LLC | $1,619.41 | 2019-2025 | Coronary Other, Zenition 70, Coronary Undivided |
| Sanofi-Aventis U.S. LLC | $1,193.84 | 2019-2023 | |
| Shockwave Medical, INC | $1,186.58 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $1,166.86 | 2023-2025 | Camzyos, Eliquis, Breyanzi |
| Vertos Medical, INC. | $855.62 | 2019 | |
| Amgen INC. | $807.57 | 2021-2025 | Repatha, Repatha, Krystexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $761.52 | 2021-2025 | Xifaxan, Trulance |
| Abiomed | $753.54 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $614.99 | 2021-2025 | |
| Biotronik INC. | $558.98 | 2019-2024 | Acticor 7 Vr-T Dx, Pamira |
| Merck Sharp & Dohme LLC | $550.07 | 2022-2025 | Verquvo, Capvaxive, Belsomra |
| Novo Nordisk INC | $448.12 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bolton Medical INC | $427.78 | 2019 | |
| Advanced Oxygen Therapy INC. | $411.29 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Gilead Sciences, INC. | $410.86 | 2019-2022 | |
| Abbvie INC. | $350.26 | 2023-2025 | |
| Cvrx, INC. | $336.17 | 2022-2023 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $332.59 | 2021-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $293.47 | 2023-2024 | Inpefa |
| Axsome Therapeutics, INC. | $246.14 | 2023-2025 | Auvelity |
| Glaxosmithkline, LLC. | $197.61 | 2022-2025 | Trelegy Ellipta |
| Asahi Intecc USA, INC. | $174.76 | 2023 | Asahi Ptca Guide Wire |
| Terumo Medical Corporation | $149.19 | 2022 | |
| Averitas Pharma INC. | $145.57 | 2023 | Qutenza |
| Ebr Systems, INC. | $141.76 | 2025 | |
| Insmed, INC. | $137.50 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $135.47 | 2020-2023 | Livalo |
| Cordis US Corp. | $133.91 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $127.14 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $121.46 | 2025 | |
| Surmodics, INC. | $115.74 | 2024 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce LP Thrombectomy |
| Siemens Medical Solutions USA, INC. | $92.95 | 2023 | |
| Bard Peripheral Vascular, INC. | $92.86 | 2020 | |
| Bridgebio Pharma, INC. | $88.27 | 2025 | Attruby |
| Lilly USA, LLC | $83.32 | 2021 | |
| Scpharmaceuticals INC. | $81.12 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $81.06 | 2023-2024 | Opsumit, Uptravi |
| Astellas Pharma US INC | $77.00 | 2019 | |
| Alnylam Pharmaceuticals INC. | $35.85 | 2025 | Amvuttra |
| Teva Pharmaceuticals USA, INC. | $33.46 | 2025 | Austedo Xr |
| Arbor Pharmaceuticals, INC. | $32.94 | 2022 | |
| Aimmune Therapeutics, INC. | $25.32 | 2025 | Zenpep |
| Ge Healthcare | $23.85 | 2024 | |
| Nestle Healthcare Nutrition INC. | $17.24 | 2023 | |
| Ibsa Pharma INC. | $17.00 | 2022 | |
| Azurity Pharmaceuticals, INC. | $16.74 | 2024 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,605.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yili Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.